跳至主要内容
临床试验/NCT00310934
NCT00310934已完成4 期

Graded Strategy for Pharmacological Treatment of Heroin Dependence

Karolinska University Hospital2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2005年8月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
96
试验地点
2
主要终点
Retention in treatment

研究概览

简要总结

The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy, where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient.

详细描述

The objective of this study is to compare optimally given methadone maintenance treatment (MMT) for heroin dependence with a novel, sequential strategy (STEP), where patients are offered buprenorphine as first line treatment, allowed dose adjustments as needed, and switched to methadone if the maximal dose of buprenorphine is insufficient.

For this purpose, 96 subjects at two centers (Uppsala and Stockholm) are randomized to MMT or STEP and followed for 6 months. Retention in treatment is the primary outcome. Secondary outcomes in completers are proportion urine samples free of illicit opiates on app. twice weekly sampling, and problem severity as measured by a semistructured interview, the Addiction Severity Index (ASI) at baseline and after 3 and 6 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heroin dependence according to DSM IV > 1year
  • Age > 20 years
  • Acceptance of the stated treatment principles.

排除标准

  • Severe psychiatric illness such as dementia or psychosis compromising the patient's ability to provide informed consent
  • Other clinically significant psychiatric illness unless stable under treatment
  • Severe medical condition such as advanced lung disease, unstable cardiovascular disease, severe liver disease
  • Other clinically significant medical condition unless stable under treatment
  • Treatment with anti-seizure drugs or disulfiram
  • Pregnancy or intent to become pregnant within the next year
  • Ongoing nursing
  • Patients involuntarily discharged from a methadone or buprenorphine maintenance program within the last 3 months not eligible.

结局指标

主要结局

Retention in treatment

次要结局

  • Proportion urine samples free of illicit drugs
  • Problem severity as measured by Addiction Severity Index

研究者

发起方
Karolinska University Hospital
申办方类型
Other

研究点 (2)

Loading locations...

相似试验